...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Thoughts on ZCC

fouremm - I'd vote against an offer to buy ZCC that included the royalty unless it was at a decent premium. Eastern Capitals position on any such proposal would also weigh heavily on my vote.

tada 

Share
New Message
Please login to post a reply